Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
SEK 0
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
About
Pexa AB engages in the development and commercialization of technology in the field of respiratory medicine. It provides lung researchers with a simple and non-invasive method for collection of microscopic particles, potential biomarkers for diseases in the small airways. The company was founded by Anna-Carin Olin in 2010 and is headquartered in Gothenburg, Sweden.
Buy
Sell